SCHEMBL7120195

SCHEMBL7120195

CCOP(=O)(CN(c1cccnc1)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.43
NR1I2 O75469 1/20 0.43
ALOX5 P09917 2/20 0.42
PTGS2 P35354 2/20 0.42
PTGS1 P23219 1/20 0.42
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
MC4R P32245 1/20 0.35
HTT P42858 1/20 0.35
CCR6 P51684 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KCNA5 P22460 3/20 0.35
KCNN4 O15554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129122 0.94 HMGCR (0.38) HMGCRNR1I2ALOX5PTGS2PTGS1
SCHEMBL8611255 0.89 ALOX5 (0.43) HMGCRNR1I2ALOX5PTGS2PTGS1
SCHEMBL8609257 0.86 HMGCR (0.43) HMGCRNR1I2ALOX5PTGS2PTGS1
SCHEMBL8766643 0.86 HMGCR (0.48) HMGCRNR1I2PTGS2LMNAALDH1A1
SCHEMBL8612757 0.86 HMGCR (0.42) HMGCRNR1I2ALOX5PTGS2PTGS1
SCHEMBL7119797 0.85 NOTUM (0.39) ALOX5PTGS2PTGS1ALDH1A1MAPT
SCHEMBL7128467 0.85 ALOX5 (0.46) ALOX5PTGS2PTGS1LMNAALDH1A1
SCHEMBL8586262 0.84 HMGCR (0.35) HMGCRNR1I2ALOX5PTGS2PTGS1
SCHEMBL7119084 0.83 ERN1 (0.39) LMNAALDH1A1MAPTALOX15MAPK1
SCHEMBL8766713 0.82 HMGCR (0.44) HMGCRNR1I2LMNAALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835116-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1998-04-15 EP claimed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP claimed
WO-1997002037-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1997-01-23 WO claimed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US claimed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP claimed
US-6660724-B1 Aminophosphonates alpha substituted by phenol; lipoprotein lowering activity ILEX PRODUCTS, INC. 2003-12-09 US disclosed
US-6060464-A Compounds and pharmaceutical compositions containing them SMITHKLINE BEECHAM P.L.C. (GB) 2000-05-09 US disclosed